Date | Time | Source | Headline | Symbol | Company |
11/04/2019 | 19:00 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/05/2018 | 18:18 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
09/04/2018 | 21:54 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/03/2018 | 18:12 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/03/2018 | 10:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/03/2018 | 10:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/03/2018 | 10:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/03/2018 | 10:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
19/03/2018 | 19:17 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
13/03/2018 | 22:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |